NLRP3 and pulmonary fibrosis: Inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis largely reversed the injurious effects of hyperoxia, resulting in attenuated lung inflammation, improved alveolarization and pulmonary vascular development, and alleviated pulmonary fibrosis.